Search - tctmd.com

Displaying 421 - 440 of 451

Sort: Relevancy | Date

Presentation TCT 2012

Autologous Cardiac Stem Cells in VAD Patients

Presenter: Robert Michler

October 23, 2012

Presentation TCT 2012

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Presenter: Peter Brady

October 23, 2012

Presentation TCT 2012

Transcatheter Interatrial Shunt for Heart Failure with Preserved Ejection Fraction (HFPEF)

Presenter: Brad Munt

October 22, 2012

Presentation TCT 2012

The Emergence of Interventional Heart Failure and Advanced Cardiac Support as an Important Clinical Subspecialty: Clinical Targets, Device Concepts, and Physician Training

Presenter: Navin Kapur

October 22, 2012

Presentation TCT 2012

CHF and Cardiomyopathy

Presenter: Michael Kim

October 21, 2012

News Conference News ESC 2012

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

August 29, 2012

News Conference News ESC 2012

Good Outlook for Heart Failure Patients Given Ventricular Restoration Device

Yael L. Maxwell

August 29, 2012

Presentation ACVS 2012

CRT: Steps To Identify Good Responder

Presenter: K. Sharada

August 04, 2012

Presentation

Contemporary Evidence About Hospital Strategies for Reducing 30-Day Readmissions

Presenter: Elizabeth H. Bradley

July 20, 2012

Presentation GI2 2012

New devices for heart failure and pulmonary hypertension

Presenter: Saibal Kar

April 12, 2012

Presentation ACC 2012

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

Presenter: Emerson C. Perin

March 25, 2012

Presentation

SDF-1 for Heart Failure

Presenter: Marc S. Penn

February 05, 2012

News Conference News Cell Therapy 2012

Novel Strategies Advance Cell Therapy for Cardiomyopathy

February 05, 2012

Presentation

Cardiac Extracorporeal Shock Waves to Enhance Intracoronary Cell Therapy in Chronic Heart Failure

Presenter: Andreas M. Zeiher

February 05, 2012

Presentation Cell Therapy 2012

Regenerative Therapy for Heart Failure: Lessons Learned and Unanswered Questions

Presenter: Les Miller

January 26, 2012

Presentation Cell Therapy 2012

SDF-1 for Heart Failure: One-Year Results of a Phase I Trial

Presenter: Marc S. Penn

January 25, 2012

Presentation Cell Therapy 2012

JD200 for Heart Failure: Safety Study

Presenter: Amit Patel

January 25, 2012

Presentation Cell Therapy 2012

Early and Next Phase Studies: Augment-HF Trial

Presenter: Randy Lee

January 25, 2012

Presentation TCT 2012

The impact of revascularization and optimal medical therapy on six-month clinical outcome in patients with and without congestive heart failure after acute myocardial infarction

Presenter: Jang Hoon Lee, Kyun Hee Kim, Won Suk Choi, Sun Hee Park, Myung Hwan Bae, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Shung Chull Chae, Jae Eun Jun, Myung Ho Jeong, Young Jo Kim

January 03, 2012

Presentation TCT 2012

Safety and Feasibility of Percutaneous Delivery of a Partial Left Ventricular Support Device (CircuLite® Synergy® Micro-Pump) in a Porcine Model

Presenter: Geng-Hua Yi, Yanping Cheng, Michael S. Aboodi, Armando Tellez, Gerard Conditt, Athanasios Peppas, Greg L. Kaluza, Rob Farnan, Arielle Drummond, Bryan Fritz, Gail Farnan, Daniel Burkhoff, Juan F. Granada

January 03, 2012

Advertisement

Autologous Cardiac Stem Cells in VAD Patients

Atrial Fibrillation:
1. CHADS2 vs. CHA2DS2-VASc Risk Assessment.
2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention.

Transcatheter Interatrial Shunt for Heart Failure with Preserved Ejection Fraction (HFPEF)

The Emergence of Interventional Heart Failure and Advanced Cardiac Support as an Important Clinical Subspecialty: Clinical Targets, Device Concepts, and Physician Training

CHF and Cardiomyopathy

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

Good Outlook for Heart Failure Patients Given Ventricular Restoration Device

CRT: Steps To Identify Good Responder

Contemporary Evidence About Hospital Strategies for Reducing 30-Day Readmissions

New devices for heart failure and pulmonary hypertension

Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial

SDF-1 for Heart Failure

Novel Strategies Advance Cell Therapy for Cardiomyopathy

Cardiac Extracorporeal Shock Waves to Enhance Intracoronary Cell Therapy in Chronic Heart Failure

Regenerative Therapy for Heart Failure: Lessons Learned and Unanswered Questions

SDF-1 for Heart Failure: One-Year Results of a Phase I Trial

JD200 for Heart Failure: Safety Study

Early and Next Phase Studies: Augment-HF Trial

The impact of revascularization and optimal medical therapy on six-month clinical outcome in patients with and without congestive heart failure after acute myocardial infarction

Safety and Feasibility of Percutaneous Delivery of a Partial Left Ventricular Support Device (CircuLite® Synergy® Micro-Pump) in a Porcine Model

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content